Narrative Review of the Role of Patient-Reported Outcomes and Inhaler Handling Errors in the Control of Asthma and COPD
Purpose of Review Asthma and chronic obstructive pulmonary disease (COPD) are chronic respiratory diseases that remain uncontrolled in many patients, despite the wide range of therapeutic options available. This review analyzes the available clinical evidence on 3 budesonide/formoterol DPI devices,...
Gespeichert in:
| Veröffentlicht in: | Current allergy and asthma reports 2022-11, Vol.22 (11), p.151-161 |
|---|---|
| Hauptverfasser: | , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 161 |
|---|---|
| container_issue | 11 |
| container_start_page | 151 |
| container_title | Current allergy and asthma reports |
| container_volume | 22 |
| creator | De Simón Gutiérrez, Raúl Castro, Raúl Piedra |
| description | Purpose of Review
Asthma and chronic obstructive pulmonary disease (COPD) are chronic respiratory diseases that remain uncontrolled in many patients, despite the wide range of therapeutic options available. This review analyzes the available clinical evidence on 3 budesonide/formoterol DPI devices, Spiromax
®
, Turbuhaler
®
, and Easyhaler
®
, in terms of patient-reported outcomes (PROs), inhaler errors, and asthma and COPD control.
Recent Findings
The effectiveness of dry powder inhalers (DPI) depends largely on the device and the patient’s inhaler technique. Equally important are the patient’s perception of the inhaler and adherence. Given the high burden of these diseases, it is important that efforts be made to select the best DPI for each patient and to analyze the impact of these variables to help improve the health and quality of life of our patients.
Summary
This review provides a comprehensive overview of the present knowledge about PROs, inhaler handling errors, and asthma and COPD control achieved by Spiromax
®
, Turbuhaler
®
, and Easyhaler
®
. |
| doi_str_mv | 10.1007/s11882-022-01041-2 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9532287</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2712845041</sourcerecordid><originalsourceid>FETCH-LOGICAL-c355t-1b44bb68282cea810e65c9b7ba39604f1452d6710a55fdd3251e4c101da406343</originalsourceid><addsrcrecordid>eNp9Uctu2zAQJIoWzaP9gR4KAr30opTLhyhfCgROmgQI4iBozwQlrWwFEumSlIP-fWk7SR-HHAjuYmeGnB1CPgA7Acb0lwhQVbxgPB9gEgr-ihyCErIoBajX25rPCi04PyBHMd4zxjONvyUHomSV5goOycONDcGmfoP0Djc9PlDf0bTKnR9wW9_mIbpU3OHah4QtXUyp8SNGal1Lr9zKDhjoZW6G3i3peQg-RNq7ncjcuxT8sNU5jWk12h1pvrg9e0fedHaI-P7xPiY_vp1_n18W14uLq_npddEIpVIBtZR1XVa84g3aChiWqpnVurZiVjLZgVS8LTUwq1TXtiJ7QtkAg9ZKVgopjsnXve56qkdsm2wl2MGsQz_a8Mt425t_J65fmaXfmJnKe6t0Fvj8KBD8zwljMmMfGxwG69BP0XANvJIqrz9DP_0HvfdTcNleRnFgWoEuM4rvUU3wMQbsnj8DzGxzNftcTc7V7HI1PJM-_m3jmfIUZAaIPSDmkVti-PP2C7K_ATbkrUc</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2721075176</pqid></control><display><type>article</type><title>Narrative Review of the Role of Patient-Reported Outcomes and Inhaler Handling Errors in the Control of Asthma and COPD</title><source>MEDLINE</source><source>SpringerLink Journals</source><creator>De Simón Gutiérrez, Raúl ; Castro, Raúl Piedra</creator><creatorcontrib>De Simón Gutiérrez, Raúl ; Castro, Raúl Piedra</creatorcontrib><description>Purpose of Review
Asthma and chronic obstructive pulmonary disease (COPD) are chronic respiratory diseases that remain uncontrolled in many patients, despite the wide range of therapeutic options available. This review analyzes the available clinical evidence on 3 budesonide/formoterol DPI devices, Spiromax
®
, Turbuhaler
®
, and Easyhaler
®
, in terms of patient-reported outcomes (PROs), inhaler errors, and asthma and COPD control.
Recent Findings
The effectiveness of dry powder inhalers (DPI) depends largely on the device and the patient’s inhaler technique. Equally important are the patient’s perception of the inhaler and adherence. Given the high burden of these diseases, it is important that efforts be made to select the best DPI for each patient and to analyze the impact of these variables to help improve the health and quality of life of our patients.
Summary
This review provides a comprehensive overview of the present knowledge about PROs, inhaler handling errors, and asthma and COPD control achieved by Spiromax
®
, Turbuhaler
®
, and Easyhaler
®
.</description><identifier>ISSN: 1529-7322</identifier><identifier>EISSN: 1534-6315</identifier><identifier>DOI: 10.1007/s11882-022-01041-2</identifier><identifier>PMID: 36087251</identifier><language>eng</language><publisher>New York: Springer US</publisher><subject>Administration, Inhalation ; Allergology ; Asthma ; Asthma (V Ortega ; Asthma (V Ortega, Section Editor) ; Asthma - drug therapy ; Bronchodilator Agents - therapeutic use ; Budesonide, Formoterol Fumarate Drug Combination - therapeutic use ; Chronic obstructive pulmonary disease ; Clinical outcomes ; Dry Powder Inhalers ; Humans ; Inhalers ; Medicine ; Medicine & Public Health ; Patient Reported Outcome Measures ; Pulmonary Disease, Chronic Obstructive - drug therapy ; Quality of Life ; Section Editor ; Topical Collection on Asthma</subject><ispartof>Current allergy and asthma reports, 2022-11, Vol.22 (11), p.151-161</ispartof><rights>The Author(s) 2022</rights><rights>2022. The Author(s).</rights><rights>The Author(s) 2022. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c355t-1b44bb68282cea810e65c9b7ba39604f1452d6710a55fdd3251e4c101da406343</cites><orcidid>0000-0002-1031-8931</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s11882-022-01041-2$$EPDF$$P50$$Gspringer$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s11882-022-01041-2$$EHTML$$P50$$Gspringer$$Hfree_for_read</linktohtml><link.rule.ids>230,314,780,784,885,27924,27925,41488,42557,51319</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/36087251$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>De Simón Gutiérrez, Raúl</creatorcontrib><creatorcontrib>Castro, Raúl Piedra</creatorcontrib><title>Narrative Review of the Role of Patient-Reported Outcomes and Inhaler Handling Errors in the Control of Asthma and COPD</title><title>Current allergy and asthma reports</title><addtitle>Curr Allergy Asthma Rep</addtitle><addtitle>Curr Allergy Asthma Rep</addtitle><description>Purpose of Review
Asthma and chronic obstructive pulmonary disease (COPD) are chronic respiratory diseases that remain uncontrolled in many patients, despite the wide range of therapeutic options available. This review analyzes the available clinical evidence on 3 budesonide/formoterol DPI devices, Spiromax
®
, Turbuhaler
®
, and Easyhaler
®
, in terms of patient-reported outcomes (PROs), inhaler errors, and asthma and COPD control.
Recent Findings
The effectiveness of dry powder inhalers (DPI) depends largely on the device and the patient’s inhaler technique. Equally important are the patient’s perception of the inhaler and adherence. Given the high burden of these diseases, it is important that efforts be made to select the best DPI for each patient and to analyze the impact of these variables to help improve the health and quality of life of our patients.
Summary
This review provides a comprehensive overview of the present knowledge about PROs, inhaler handling errors, and asthma and COPD control achieved by Spiromax
®
, Turbuhaler
®
, and Easyhaler
®
.</description><subject>Administration, Inhalation</subject><subject>Allergology</subject><subject>Asthma</subject><subject>Asthma (V Ortega</subject><subject>Asthma (V Ortega, Section Editor)</subject><subject>Asthma - drug therapy</subject><subject>Bronchodilator Agents - therapeutic use</subject><subject>Budesonide, Formoterol Fumarate Drug Combination - therapeutic use</subject><subject>Chronic obstructive pulmonary disease</subject><subject>Clinical outcomes</subject><subject>Dry Powder Inhalers</subject><subject>Humans</subject><subject>Inhalers</subject><subject>Medicine</subject><subject>Medicine & Public Health</subject><subject>Patient Reported Outcome Measures</subject><subject>Pulmonary Disease, Chronic Obstructive - drug therapy</subject><subject>Quality of Life</subject><subject>Section Editor</subject><subject>Topical Collection on Asthma</subject><issn>1529-7322</issn><issn>1534-6315</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>C6C</sourceid><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><recordid>eNp9Uctu2zAQJIoWzaP9gR4KAr30opTLhyhfCgROmgQI4iBozwQlrWwFEumSlIP-fWk7SR-HHAjuYmeGnB1CPgA7Acb0lwhQVbxgPB9gEgr-ihyCErIoBajX25rPCi04PyBHMd4zxjONvyUHomSV5goOycONDcGmfoP0Djc9PlDf0bTKnR9wW9_mIbpU3OHah4QtXUyp8SNGal1Lr9zKDhjoZW6G3i3peQg-RNq7ncjcuxT8sNU5jWk12h1pvrg9e0fedHaI-P7xPiY_vp1_n18W14uLq_npddEIpVIBtZR1XVa84g3aChiWqpnVurZiVjLZgVS8LTUwq1TXtiJ7QtkAg9ZKVgopjsnXve56qkdsm2wl2MGsQz_a8Mt425t_J65fmaXfmJnKe6t0Fvj8KBD8zwljMmMfGxwG69BP0XANvJIqrz9DP_0HvfdTcNleRnFgWoEuM4rvUU3wMQbsnj8DzGxzNftcTc7V7HI1PJM-_m3jmfIUZAaIPSDmkVti-PP2C7K_ATbkrUc</recordid><startdate>20221101</startdate><enddate>20221101</enddate><creator>De Simón Gutiérrez, Raúl</creator><creator>Castro, Raúl Piedra</creator><general>Springer US</general><general>Springer Nature B.V</general><scope>C6C</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-1031-8931</orcidid></search><sort><creationdate>20221101</creationdate><title>Narrative Review of the Role of Patient-Reported Outcomes and Inhaler Handling Errors in the Control of Asthma and COPD</title><author>De Simón Gutiérrez, Raúl ; Castro, Raúl Piedra</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c355t-1b44bb68282cea810e65c9b7ba39604f1452d6710a55fdd3251e4c101da406343</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Administration, Inhalation</topic><topic>Allergology</topic><topic>Asthma</topic><topic>Asthma (V Ortega</topic><topic>Asthma (V Ortega, Section Editor)</topic><topic>Asthma - drug therapy</topic><topic>Bronchodilator Agents - therapeutic use</topic><topic>Budesonide, Formoterol Fumarate Drug Combination - therapeutic use</topic><topic>Chronic obstructive pulmonary disease</topic><topic>Clinical outcomes</topic><topic>Dry Powder Inhalers</topic><topic>Humans</topic><topic>Inhalers</topic><topic>Medicine</topic><topic>Medicine & Public Health</topic><topic>Patient Reported Outcome Measures</topic><topic>Pulmonary Disease, Chronic Obstructive - drug therapy</topic><topic>Quality of Life</topic><topic>Section Editor</topic><topic>Topical Collection on Asthma</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>De Simón Gutiérrez, Raúl</creatorcontrib><creatorcontrib>Castro, Raúl Piedra</creatorcontrib><collection>Springer Nature OA Free Journals</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Current allergy and asthma reports</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>De Simón Gutiérrez, Raúl</au><au>Castro, Raúl Piedra</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Narrative Review of the Role of Patient-Reported Outcomes and Inhaler Handling Errors in the Control of Asthma and COPD</atitle><jtitle>Current allergy and asthma reports</jtitle><stitle>Curr Allergy Asthma Rep</stitle><addtitle>Curr Allergy Asthma Rep</addtitle><date>2022-11-01</date><risdate>2022</risdate><volume>22</volume><issue>11</issue><spage>151</spage><epage>161</epage><pages>151-161</pages><issn>1529-7322</issn><eissn>1534-6315</eissn><abstract>Purpose of Review
Asthma and chronic obstructive pulmonary disease (COPD) are chronic respiratory diseases that remain uncontrolled in many patients, despite the wide range of therapeutic options available. This review analyzes the available clinical evidence on 3 budesonide/formoterol DPI devices, Spiromax
®
, Turbuhaler
®
, and Easyhaler
®
, in terms of patient-reported outcomes (PROs), inhaler errors, and asthma and COPD control.
Recent Findings
The effectiveness of dry powder inhalers (DPI) depends largely on the device and the patient’s inhaler technique. Equally important are the patient’s perception of the inhaler and adherence. Given the high burden of these diseases, it is important that efforts be made to select the best DPI for each patient and to analyze the impact of these variables to help improve the health and quality of life of our patients.
Summary
This review provides a comprehensive overview of the present knowledge about PROs, inhaler handling errors, and asthma and COPD control achieved by Spiromax
®
, Turbuhaler
®
, and Easyhaler
®
.</abstract><cop>New York</cop><pub>Springer US</pub><pmid>36087251</pmid><doi>10.1007/s11882-022-01041-2</doi><tpages>11</tpages><orcidid>https://orcid.org/0000-0002-1031-8931</orcidid><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1529-7322 |
| ispartof | Current allergy and asthma reports, 2022-11, Vol.22 (11), p.151-161 |
| issn | 1529-7322 1534-6315 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9532287 |
| source | MEDLINE; SpringerLink Journals |
| subjects | Administration, Inhalation Allergology Asthma Asthma (V Ortega Asthma (V Ortega, Section Editor) Asthma - drug therapy Bronchodilator Agents - therapeutic use Budesonide, Formoterol Fumarate Drug Combination - therapeutic use Chronic obstructive pulmonary disease Clinical outcomes Dry Powder Inhalers Humans Inhalers Medicine Medicine & Public Health Patient Reported Outcome Measures Pulmonary Disease, Chronic Obstructive - drug therapy Quality of Life Section Editor Topical Collection on Asthma |
| title | Narrative Review of the Role of Patient-Reported Outcomes and Inhaler Handling Errors in the Control of Asthma and COPD |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T02%3A39%3A45IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Narrative%20Review%20of%20the%20Role%20of%20Patient-Reported%20Outcomes%20and%20Inhaler%20Handling%20Errors%20in%20the%20Control%20of%20Asthma%20and%20COPD&rft.jtitle=Current%20allergy%20and%20asthma%20reports&rft.au=De%20Sim%C3%B3n%20Guti%C3%A9rrez,%20Ra%C3%BAl&rft.date=2022-11-01&rft.volume=22&rft.issue=11&rft.spage=151&rft.epage=161&rft.pages=151-161&rft.issn=1529-7322&rft.eissn=1534-6315&rft_id=info:doi/10.1007/s11882-022-01041-2&rft_dat=%3Cproquest_pubme%3E2712845041%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2721075176&rft_id=info:pmid/36087251&rfr_iscdi=true |